In addition, a head-to-head trial of semaglutide and liraglutide was conducted in the STEP 8 trial, with a mean weight loss of 17.1% in the semaglutide group, which was significantly more effective than liraglutide (mean weight loss of 6.6%)
The chart below shows the key differences between GLP-1 weight loss medications, Phentermine, Cell-Press, and I AM WonderFULL
Nausea most likely in this phase
The American pharma company looks intent on closing the gap with Novo Nordisk and Eli Lilly, both of which have been dominating the global GLP-1 market for a while now
Figure 38: Photograph of the team who developed semaglutide
The compound has become a subject of increasing interest within peptide science due to its triple-receptor profile and its role in metabolic signaling research